21:00:25 EDT Thu 03 Sep 2026
Enter Symbol
or Name
USA
CA



A-Labs Capital II Corp
Symbol ALAB
Shares Issued 7,762,900
Close 2026-08-12 C$ 0.055
Market Cap C$ 426,960
Recent Sedar+ Documents

A-Labs Capital II arranges $5,000 private placement

2026-09-03 18:42 ET - News Release

Subject: ALabs | Press Release Word Document

File: '\\swfile\EmailIn\20260903 152038 Attachment ALabs - 20260903 - PR - Announce Share Financing-final.docx'

A-Labs Capital II Corp. Announces Non-Brokered Financing

VANCOUVER, BC, September 3, 2026 - A-Labs Capital II Corp. ("ALabs" or the "Company") announces a non-brokered private placement of 100,000 common shares (the "Shares") at a price of $0.05 per Share, for gross proceeds up to $5,000 (the "Offering").

The Shares issued under the Offering will be subject to a statutory four-month hold period and escrow under applicable Canadian securities legislation and TSX Venture Exchange ("TSXV") policies. The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSXV and the applicable securities regulatory authorities. No commission or finder's fees will be paid in connection with the Offering, and the Offering will not result in a new control person.

The Company expects to rely on exemptions from the formal valuation requirements of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). Specifically the Company is relying upon Subsection 5.5(a) of MI-61-101 (as the Company's common shares are listed only on the TSXV), and from the minority shareholder approval requirements of MI 61-101, pursuant to Subsection 5.7(1)(b) of MI 61-101 (as neither the fair market value of the Shares to be issued to insiders nor the consideration to be paid by insiders pursuant to the Offering is expected to exceed 25 per cent of the Company's market capitalization, as determined in accordance with MI 61-101).

The Company intends to use the proceeds from the Offering for general working capital purposes.

For further information contact:

Sebastian Wahl

A-Labs Capital II Corp.

s.wahl@pirin.capital

+359-88-599-4300

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information other than statements of historical facts contained in this news release constitutes "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information"). Without limiting the foregoing, such forward-looking information includes statements regarding the Offering, Company's business plans, expectations, capital costs and objectives. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking information. Forward-looking information should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information is based on information available at the time and/or the Company management's good faith belief with respect to future events and is subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. The forward-looking information set forth herein reflects the Company's expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

© 2026 Canjex Publishing Ltd. All rights reserved.